ABUS Arbutus Biopharma Corporation

2.70
+0  (0%)
Previous Close 2.70
Open 2.70
Price To book 0.36
Market Cap 148.07M
Shares 54,841,000
Volume 49,633
Short Ratio 2.61
Av. Daily Volume 332,453

SEC filingsSee all SEC filings

  1. 8-K - Current report 17587955
  2. SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals 17586209
  3. 8-K - Current report 17580833
  4. 424B2 - Prospectus [Rule 424(b)(2)] 17538297
  5. EFFECT - Notice of Effectiveness 17537456

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2 single dose data released September 2016, multiple dose data released December 12, 2016.
ARB-1467
Hepatitis B (HBV)
Phase 1/2 data released July 2016. Intends to explore partnership opportunities to enable further study
TKM-PLK1
Hepatocellular carcinoma (HCC)

Latest News

  1. Doylestown biopharm firm granted injunction over licensing dispute
  2. ARBUTUS BIOPHARMA CORP Files SEC form 8-K, Other Events
  3. Arbutus to Participate in Upcoming Investor Conferences
  4. ARBUTUS BIOPHARMA CORP Files SEC form 8-K, Other Events
  5. Arbutus Is Granted a Pre-trial Injunction Restraining Acuitas From Entering Into Agreements Sublicensing Arbutus LNP Technology
  6. Celgene Issues Preliminary 2016 Results, Lifts 2017 View
  7. Ionis, Novartis Ink Deal to Focus on Cardiovascular Treatments
  8. Alexion Blood Disorder Drug Gets Orphan Designation in U.S.
  9. The Medicines Co LDL-Lowering Drug Positive in Phase II
  10. Ultragenyx's (RARE) KRN23 Accepted for Review in the EU
  11. Bayer's sNDA for Stivarga Granted Priority Review in the U.S.
  12. Ionis (IONS) Stock Up on Positive Type II Diabetes Drug Data
  13. Innocoll (INNL) Down on FDA's Refusal to File Xaracoll NDA
  14. Fortress Biotech (FBIO) in Focus: Stock Moves 20.9% Higher
  15. Galena Biopharma Reveals Regulatory Pathway for GALE-401
  16. Intercept Pharmaceuticals (ICPT) Jumps: Stock Rises 9.3%
  17. Anthera (ANTH) Stock Falls on Poor Phase III Sollpura Data
  18. NewLink Genetics (NLNK) Jumps: Stock Adds 10% in Session
  19. Spring Bank (SBPH) Inks 3rd Collaboration Agreement
  20. Alexion Soliris Fails in Phase II/III Delayed Graft Function Study